GertrudMallett517

The researchers analyzed four drugs: Allegra, Arava, Amaryl and Zithromax. In the next half of 2005, all these drugs run out of patent protection. Their universal equivalents were ordered instead at a typical factor of 87 % within 1 month of the equivalents supply at pharmacies.

The research was organized by Medco Health Solutions Inc. Located in Frankin Lakes, which will be the greatest drug profit management company in U.S. The business deals for low rates of prescription drug with respect to its clients.

In line with the study, Zithromax, the blockbuster of Pfizer Inc. with its annual sales of $1.85 billion was rapidly taken at pharmacies by simple equivalent at a 90 % rate just after it lost its patent protection in November.

The study authors mentioned the alternative of Zithromax, an for respiratory infections, as evidence that more and more doctors propose common versions of manufacturer drugs more easily, even if it is about so-called acute care drugs, such as Zithromax.

The really good news is these four generic medications are only the start. With a number of popular drugs anticipated to move off patent in the next a long period, substantial prescription drug costs savings should be seen by us - stated a senior vice president, Dr. Glen Stettin.

A spokeswoman at Medco, Ann Smith stated that more than 70 brand name drugs, including 19 blockbusters, are losing their patent protection within the next five years - with total annually sales of $45 billion.

If Medcos study shows a long-term trend, in the coming years people, companies and insurance firms helps you to save billions of dollars in prescription drug - Smith said.

The information met with enthusiastic response from consumer groups.

Develop the trend continues. Its good for consumers, revealed Bill Vaughan, senior policy analyst for an group, Consumer Union, located in Washington, D.C.

Vaughan stated that past fears in regards to the safety and effectiveness of common drugs have apparently started to disappear as society has become more worried about rapid increase of health-care costs.

The FDA approves these generic drugs simply because they have now been decided just like safe and effective as their manufacturer counterparts, nevertheless you pay a fraction of the price, Vaughan said. We think that is very good and can save yourself consumers literally billions of dollars next couple of years.

At the same time, large pharmaceutical organizations have claimed that their brand name drugs will not be replaced by knockoffs as insurers and doctors recognize that the brand name drugs promise better treatment and in consequence - save money.

Hank McKinnell, Pfizer Chairman used that argument during last session with authorities in New York.

In the event that you dont just like the high cost of medical care, attempt the high cost of sickness, McKinnell recommended. cheap canadian pharmacy